GnRH Agonist Alone vs. GnRH Agonist Plus Anti-androgen Combination Treated Prostate Cancer Patients
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen Agent (NCT01303692) | AstraZeneca | 2011-04-01 |
Track GnRH Agonist Alone vs. GnRH Agonist Plus Anti-androgen Combination Treated Prostate Cancer Patients automatically
Every clearance here is in the API, with alerts when new ones post.